1. Home
  2. Analysis
  3. Frovatriptan-succinate
  4. Rabeprazole

Frovatriptan succinate and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Frovatriptan succinate (frovatriptan succinate) and Rabeprazole (rabeprazole sodium). Common drug interactions include angioedema among females.

The phase IV clinical study analyzes what interactions people have when they take Frovatriptan succinate and Rabeprazole. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Frovatriptan succinate?

Frovatriptan succinate has active ingredients of frovatriptan succinate. eHealthMe is studying from 358 Frovatriptan succinate users. Check the latest studies of Frovatriptan succinate.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

On Aug, 02, 2026

90 people who take Frovatriptan succinate and Rabeprazole together, and have interactions are studied.

Frovatriptan succinate and Rabeprazole drug interactions.

What are the common drug interactions of Frovatriptan Succinate and Rabeprazole, by gender? *:

female:

  1. Angioedema (rapid swelling of the dermis)
  2. Drug intolerance (drug sensitivity)
  3. Injection site bruising
  4. Injection site pain
  5. Injection site reaction
  6. Injection site urticaria (rash of round, red welts on the skin at injection site)
  7. Migraine (headache)
  8. Neck pain
  9. Presyncope
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

male:

n/a

What are the common drug interactions of Frovatriptan Succinate and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Angioedema (rapid swelling of the dermis)
  2. Drug intolerance (drug sensitivity)
  3. Dysphonia (speech disorder attributable to a disorder of phonation)
  4. Headache (pain in head)
  5. Hypersensitivity
  6. Swelling face
  7. Swollen tongue (swelling of tongue)
  8. Drug ineffective

50-59:

n/a

60+:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Cardiac arrest
  3. Drug ineffective
  4. Injection site bruising
  5. Injection site pain
  6. Injection site reaction
  7. Injection site urticaria (rash of round, red welts on the skin at injection site)
  8. Migraine (headache)
  9. Neck pain
  10. Presyncope

What are the existing conditions these people have? *

  1. Migraine (headache): 90 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Frovatriptan succinate and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Frovatriptan succinate and Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Frovatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Frovatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on frovatriptan succinate and rabeprazole sodium (the active ingredients of Frovatriptan succinate and Rabeprazole, respectively), and Frovatriptan succinate and Rabeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.